Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Targeted Growth, Inc. (TGI) is an agricultural biotechnology company based in Seattle, Washington, that focuses on developing technologies to increase crop yield and enhance the production of biofuels. The company utilizes its proprietary "Targeted Growth" technology, which involves the regulation of the cell cycle to increase seed size and overall plant biomass. TGI has applied its platform to a variety of crops, including corn, soybeans, and Camelina, and has established significant partnerships with major agricultural players like Monsanto and Bayer. Through its subsidiary, Sustainable Oils, the company has been a leader in the development of Camelina as a low-carbon feedstock for renewable jet fuel and biodiesel.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Targeted Growth.